| Cat. No. | 
                Product Name | 
                
                Information | 
            
            
                
            	| PC-36021 | 
                
                	
                		 GO289 
                       
                  	
                    CK2 inhibitor 
                 | 
                
                GO289 (GO-289, GO 289) is a potent and selective inhibitor of casein kinase 2 (CK2) with IC50 of 7 nM in in vitro kinase assays, shows minor effects on CKIδ and CKIα activity in vitro. | 
            
            
                
            	| PC-35629 | 
                
                	
                		 BTX161 
                       
                  	
                    CK1α degrader  
                 | 
                
                BTX161 is a thalidomide analog that mediates degradation of CKIα better than lenalidomide in human AML cells and activates DDR and p53, while stabilizing the p53 antagonist MDM2. | 
            
            
                
            	| PC-35628 | 
                
                	
                		 Casein Kinase inhibitor A86 
                       
                  	
                    CK1α inhibitor, CDK7/9 inhibitor 
                 | 
                
                Casein Kinase inhibitor A86 (CK1α inhibitor A86) is a novel pan-specific CK1 (CSNK1) inhibitor (Kd=1-10 nM, CK1α Kd=9.8 nM) that co-targets the transcriptional kinases CDK7 and CDK9, with hardly inhibition of CDK8, CDK13, CDK11a, CDK11b, and CDK19. | 
            
            
                
            	| PC-35627 | 
                
                	
                		 BTX-A51 
                       
                  	
                    CK1α inhibitor, CDK7/9 inhibitor 
                 | 
                
                BTX-A51 (CK1α inhibitor A51) is a novel pan-specific CK1 (CSNK1) inhibitor (Kd=0.5-20 nM, CK1α Kd=5.3 nM) that co-targets the transcriptional kinases CDK7 and CDK9, with hardly inhibition of CDK8, CDK13, CDK11a, CDK11b, and CDK19. | 
            
            
                
            	| PC-35616 | 
                
                	
                		 BMS-699 
                       
                  	
                    CK2 inhibitor 
                 | 
                
                BMS-699 (BMS699) is a novel potent, selective, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50 of 0.1 nM (CKα). | 
            
            
                
            	| PC-35614 | 
                
                	
                		 BMS-595 
                       
                  	
                    CK2 inhibitor 
                 | 
                
                BMS-595 (BMS595) is a novel potent, selective, ATP-competitive casein kinase 2 (CK2) inhibitor with IC50 of 1.3 nM (CKα). | 
            
            
                
            	| PC-35185 | 
                
                	
                		 CAM4712 
                       
                  	
                    CK2α inhibitor 
                 | 
                
                CAM4712 (CAM-4712) is a potent and selective CK2alpha (CK2α) inhibitor with IC50 of 7 uM, exhibits cell growth inhibition in HCT116 cell line with IC50 of 10 uM. | 
            
            
                
            	| PC-35184 | 
                
                	
                		 CAM4066 
                       
                  	
                    CK2α inhibitor 
                 | 
                
                CAM4066 (CAM-4066) is a potent and selective CK2alpha (CK2α) inhibitor with Kd of 0.32 uM and IC50 of 0.37 uM, shows significantly improved selectivity compared to other CK2α inhibitors. | 
            
            
                
            	| PC-43200 | 
                
                	
                		 IC261 
                       
                  	
                    CK1δ/CK1ε inhibitor 
                 | 
                
                IC261 (IC-261, SU-5607) is a potent, specific, ATP-competitive CK1delta/epsilon (CK1δ/CK1ε) with IC50 of 1 uM, does not block the activity of α, β and γ isoforms. | 
            
            
                
            	| PC-62834 | 
                
                	
                		 CK1-IN-3c 
                       
                  	
                    CK1δ/ε inhibitor 
                 | 
                
                CK1-IN-3c is a novel casein kinase 1δ/ε (CK1δ/ε) inhibitor with IC50 of 1.6 uM. | 
            
            
                
            	| PC-62346 | 
                
                	
                		 CK2-IN-1 
                       
                  	
                    CK2 inhibitor 
                 | 
                
                CK2-IN-1 is a potent, competitive inhibitor of ATP binding to Casein kinase 2 (CK2) with IC50 of 9 nM, induces differentiation of epidermal progenitor cells to terminally differentiated keratinocytes with EC50 of 0.1 uM. | 
            
            
                
            	| PC-62192 | 
                
                	
                		 Quinalizarin 
                       
                  	
                    CK2 inhibitor 
                 | 
                
                Quinalizarin is a potent, selective and cell-permeable inhibitor of CK2 with Ki of 58 nM. |